Neuroradiology: Page 208

MRI study indicates cognitive impairment after chemo for breast cancer
By Peggy Peck
Breast cancer patients who have undergone chemotherapy were more likely to self-report cognitive impairment, and demonstrated neurological shifts on functional MRI (fMRI) tests, but these changes did not always translate to formal cognitive test results, according to a new study by researchers from London.
July 13, 2006
Guardian begins clinical evaluation of 3i technology
By AuntMinnie.com staff writers
RIS/PACS vendor Guardian Technologies International of Herndon, VA, has agreed to have PACS pioneer H. K. (Bernie) Huang clinically evaluate the company's 3i intelligent imaging analysis algorithm for medical imaging.
July 12, 2006
Kyron gets Prism clearance
By AuntMinnie.com staff writers
MRI advanced visualization application developer Kyron Clinical Imaging has received U.S. Food and Drug Administration clearance to market its Prism Acquire and Prism Process brain imaging products in the U.S.
July 10, 2006
PET trumps MRI for brain cancer chemo response
By Jonathan S. Batchelor
Monitoring the effectiveness of chemotherapy for brain cancer is a critical element in the treatment of the disease. A recent study by French researchers indicates that monitoring chemotherapy efficacy with FDG-PET may detect recurrence of high-grade glioma earlier than imaging studies conducted with MRI.
July 6, 2006
NeuroLogica inks Columbia-Presbyterian deal
By AuntMinnie.com staff writers
Mobile CT developer NeuroLogica of Danvers, MA, has sold one of its CereTom mobile CT scanners to Columbia-Presbyterian Medical Center in New York City.
July 5, 2006
Philips, Dartmouth partner
By AuntMinnie.com staff writers
Philips Medical Systems said it will collaborate with the Dartmouth Medical School and Thayer School of Engineering at Dartmouth College in Lebanon, NH, on the development of new medical imaging capabilities.
July 5, 2006
Diagnosis murder: Imaging as a psycholegal defense tool
If the current crop of TV shows is any indication, medical imaging is primed to replace forensics as the cool crime-fighting science. In real-life crime dramas, imaging is being deployed as a defense tool for those looking to back up a plea of legal insanity. AuntMinnie.com investigates the use of scanning as a psycholegal defense tool and as a major component of the emerging field of neuroethics.
June 28, 2006
2006 06 23 14 19 48 706
Pain processing centers in brain show decreased activity in self-mutilators
By Shalmali Pal
Using functional MRI, European mental health specialists have demonstrated how patients with borderline personality disorder neurologically adapt to pain thresholds and processing, allowing them to down-regulate the emotional components of the brain that monitor pain and continue to engage in self-injury.
June 27, 2006
Molecular Insight starts phase I neuroendocrine cancer trial
By AuntMinnie.com staff writers
Molecular Insight Pharmaceuticals has begun a phase I clinical trial of its Azedra molecular imaging pharmaceutical for the treatment of neuroendocrine tumors such as carcinoid, pheochromocytoma, and neuroblastoma.
June 21, 2006
Philips, UAB collaborate
By AuntMinnie.com staff writers
Philips Medical Systems said it will outfit the University of Alabama at Birmingham (UAB) Health System's new heart and vascular center.
June 18, 2006
Dual-source imaging promises better CT scanning
By Eric Barnes
SAN FRANCISCO - Dual-source CT (DSCT) promises big gains -- principally in terms of speed and power -- for imaging applications that have traditionally been starved for one or both, according to presentations at this week's International Symposium on Multidetector-Row CT.
June 14, 2006
Syntermed highlights software
By AuntMinnie.com staff writers
Imaging software developer Syntermed of Atlanta highlighted its family of software products for advanced visualization and image analysis at the Society of Nuclear Medicine (SNM) show in San Diego.
June 6, 2006
Previous Page
Page 208 of 238
Next Page